Tau pathology in the brain leads to functional impairments, and previous studies have shown that TauPS19 mice exhibit cognitive deficits by 9 months of age, as assessed by the novel object recognition (NOR) [37] and Y-Maze [38] behavioral tests. The gene discussed is MAPT; the disease is Cognitive impairment.